SQZ Biotechnologies Co
SQZ Biotechnologies Co (SQZB): 7 pipeline candidates · ~3 mo cash runway · 2 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
2.6 months
D/E 14.84 · 0% dilution
Lead: Phase 1/Phase 2
7 candidates
N/A
N/A
A transparent, data-derived signal for SQZ Biotechnologies Coacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$708K
Cash
$12.5M
Quarterly Burn
$14.5M
Runway
2.6 mo
Revenue
$0
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (7 candidates)
| Drug | Phase |
|---|---|
| commercial influenza vaccine | Phase 1/Phase 2 |
| gc012f | Phase 1/Phase 2 |
| recombinant influenza vaccine candidate | Phase 1/Phase 2 |
| sqz-aac-hpv | Phase 1 |
| sqz-eapc-hpv | Phase 1/Phase 2 |
| sqz-pbmc-hpv | Phase 1 |
| tac-celiac | Preclinical |
Institutional Holdings
Source: SEC Form 13F · as of Sep 2023Institutional holders
5
Total value held
$203K
| Holder | Shares | Value |
|---|---|---|
| american international group, inc. | 2,517,173 | $202K |
| bangor savings bank | 11,357 | $911 |
| artal group s.a. | 1,606,309 | $129 |
| ronald blue trust, inc. | 4,195 | $1 |
| barclays plc | 1,794 | $0 |
Frequently asked questions
How many drug candidates are in SQZ Biotechnologies Co's pipeline?
SQZ Biotechnologies Co (SQZB) has 7 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is SQZ Biotechnologies Co's lead drug candidate?
SQZ Biotechnologies Co's most advanced tracked candidate is commercial influenza vaccine (Phase 1/Phase 2) for Influenza.
What is SQZ Biotechnologies Co's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, SQZ Biotechnologies Co has approximately 2.6 months of cash runway.
What is SQZ Biotechnologies Co's market capitalization?
SQZ Biotechnologies Co's market capitalization is approximately $708K.
Who is the CEO of SQZ Biotechnologies Co?
Howard Bernstein, M.D. is the chief executive officer of SQZ Biotechnologies Co (SQZB).
Get the full picture on SQZ Biotechnologies Co
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.